/Investor DB

Sofinnova Partners — 2015 Investments

3 investments dated 2015 · listed companies and verified rows first · show all

Asceneuronasceneuron.comin𝕏Series A · Sep 2015 · $31M✓ verified

Biotech

Co-investorsKurma PartnersJohnson & Johnson Innovation – JJDCM VenturesSR One Capital ManagementEQT Life Sciences

Gensight Biologics S.Agensight-biologics.comin𝕏Jul 2015

GenSight Biologics develops clinical-stage gene therapy treatments, with a lead candidate (GS010/LUMEVOQ) in development for rare genetic diseases.

BiotechDigital HealthHealthtechMedical DevicesParis, FR

Bernard Gilly(Executive Officer, Director)inJean-Philippe Combal(Executive Officer)inThomas Gidoin(Executive Officer)Didier Pruneau(Executive Officer)inNitza Thomasson(Executive Officer)in

BoardFlorent Gros(Director)

Co-investorsAgoranovAbingworth

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Comet Biorefining

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.